Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CADM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MIATNB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TAF8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101060363 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPH3AL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL23A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MICAL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP32 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF175 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAS1RR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPER1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AIF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100507652 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RTF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL17A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AKAIN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on